UAP56 is an important mediator of Angiotensin II/platelet derived growth factor induced vascular smooth muscle cell DNA synthesis and proliferation

被引:5
作者
Sahni, Abha [1 ,2 ]
Wang, Nadan [1 ,3 ]
Alexis, Jeffrey [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Dept Med, Rochester, NY 14642 USA
[2] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA
[3] Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA
关键词
Proliferation; DNA synthesis; UAP56; Helicase; P68 RNA HELICASE; E2F; EXPORT; DECOY; PHOSPHORYLATION; ACTIVATION; EXPRESSION; PROTEINS; STRATEGY; PRODUCT;
D O I
10.1016/j.bbrc.2012.12.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Angiotensin (Ang) II and platelet-derived growth factor (PDGF) are important mediators of pathologic vascular smooth muscle cell (VSMC) proliferation. Identifying downstream mediators of Ang II and PDGF signaling may provide insights for therapies to improve vascular proliferative diseases. We have previously demonstrated that breakpoint cluster region (Bcr) is an important mediator of Ang II/PDGF signaling in VSMC. We have recently reported that the DExD/H box protein UAP56 is an interacting partner of Bcr in regulating VSMC DNA synthesis. We hypothesized that UAP56 itself is an important regulator of VSMC proliferation. In this report we demonstrate that knockdown of UAP56 inhibits Ang II/PDGF induced VSMC DNA synthesis and proliferation, and inhibits E2F transcriptional activity. In addition, we demonstrate that UAP56 is present in the vessel wall of low-flow carotid arteries. These findings suggest that UAP56 is a regulator of VSMC proliferation and identify UAP56 as a target for preventing vascular proliferative disease. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:636 / 640
页数:5
相关论文
共 27 条
[1]  
ABE J, 1994, CANCER RES, V54, P3407
[2]  
AKAO Y, 1995, CANCER RES, V55, P3444
[3]   Bcr Kinase Activation by Angiotensin II Inhibits Peroxisome Proliferator-Activated Receptor γ Transcriptional Activity in Vascular Smooth Muscle Cells [J].
Alexis, Jeffrey D. ;
Wang, Nadan ;
Che, Wenyi ;
Lerner-Marmarosh, Nicole ;
Sahni, Abha ;
Korshunov, Vyacheslav A. ;
Zou, Yiping ;
Ding, Bo ;
Yan, Chen ;
Berk, Bradford C. ;
Abe, Jun-ichi .
CIRCULATION RESEARCH, 2009, 104 (01) :69-78
[4]   The E2F family: specific functions and overlapping interests [J].
Attwooll, C ;
Denchi, EL ;
Helin, K .
EMBO JOURNAL, 2004, 23 (24) :4709-4716
[5]   E2F target genes: unraveling the biology [J].
Bracken, AP ;
Ciro, M ;
Cocito, A ;
Helin, K .
TRENDS IN BIOCHEMICAL SCIENCES, 2004, 29 (08) :409-417
[6]   RECEPTOR-MEDIATED EFFECTS OF ANGIOTENSIN-II ON GROWTH OF VASCULAR SMOOTH-MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE RATS [J].
BUNKENBURG, B ;
VANAMELSVOORT, T ;
ROGG, H ;
WOOD, JM .
HYPERTENSION, 1992, 20 (06) :746-754
[7]   Emerging roles of E2Fs in cancer: an exit from cell cycle control [J].
Chen, Hui-Zi ;
Tsai, Shih-Yin ;
Leone, Gustavo .
NATURE REVIEWS CANCER, 2009, 9 (11) :785-797
[8]  
DUFF JL, 1993, J BIOL CHEM, V268, P26037
[9]   Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy [J].
Ehsan, A ;
Mann, MJ ;
Dell'Acqua, G ;
Dzau, VJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (04) :714-722
[10]   Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells [J].
Fujita, N ;
Furukawa, Y ;
Itabashi, N ;
Okada, K ;
Saito, T ;
Ishibashi, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (01) :H204-H212